|
Case Name |
Date Filed |
Judge |
Drug |
Patent |
|
Purdue Pharma. Products L.P. v. Dr. Reddy’s Labs., Inc., 13-2067 (D.N.J.) |
Apr. 2, 2013 |
Hon. Jose L. Linares |
Intermezzo®(zolpidem tartrate sublingual tablet) |
7,682,628 8,242,131 8,252,809 |
|
Novartis Pharma. Corp. v. Noven Pharma., Inc., 13-0527 (D. Del.) |
Apr. 3, 2013 |
Hon. Richard G. Andrews |
Exelon®Patch (rivastigmine transdermal system or extended-release film) |
6,316,023 6,335,031 |
|
Novartis Pharma. Corp. v. Accord Healthcare Inc., 13-2379 (D.N.J.) |
Apr. 12, 2013 |
Hon. Susan D. Wigenton |
Zometa®(zoledronic acid injection) |
8,324,189 |
|
Braintree Labs., Inc. v. Gator Pharma., Inc., 13-0389 (M.D. Fla.) |
Apr. 15, 2013 |
Hon. Timothy J. Corrigan |
Suprep®Bowel Prep Kit (sodium sulfate / potassium sulfate / magnesium sulfate) |
6,946,149 |
|
Braintree Labs., Inc. v. Gator Pharma., Inc., 13-1975 (E.D. Pa.) |
Apr. 15, 2013 |
Hon. Paul S. Diamond |
Suprep®Bowel Prep Kit (sodium sulfate / potassium sulfate / magnesium sulfate) |
6,946,149 |
|
Shionogi & Co., Ltd. v. Hospira, Inc., 13-2400 (D.N.J.) |
Apr. 15, 2013 |
Hon. Freda L. Wolfson |
Doribax®(doripenem for injection) |
8,247,402 |
|
Helsinn Healthcare S.A. v. Aurobindo Pharma Ltd., 13-0688 (D. Del.) |
Apr. 16, 2013 |
Hon. Sherry R. Fallon |
Aloxi®(palonosetron hydrochloride intravenous solution) |
7,947,724 7,947,725 7,960,424 |
|
Pfizer Inc. v. Inventia Healthcare Private Ltd., 13-2986 (N.D. Ill.) |
Apr. 19, 2013 |
Hon. Edmond E. Chang |
Detrol®LA (tolterodine tartrate extended-release capsules) |
6,630,162 6,770,295 |
|
Par Pharma., Inc. v. Takeda Pharma. Co., Ltd., 13-1927 (N.D. Ca.) |
Apr. 26, 2013 |
Hon. Lucy H. Koh |
Dexilant®(dexlansoprazole capsules) |
8,105,626 8,173,158 |
|
Acura Pharma., Inc. v. Ranbaxy Inc., 13-0750 (D. Del.) |
Apr. 29, 2013 |
Hon. Richard G. Andrews |
Oxecta®(oxycodone hydrochloride tablets) |
7,510,726 |
|
The Medicines Co. v. Apotex Inc., 13-2801 (D.N.J.) |
May 1, 2013 |
Hon. Peter G. Sheridan |
Angiomax®(bivalirudin for injection) |
7,582,727 7,598,343 |
|
AstraZeneca AB v. Watson Labs., Inc.—Florida, 13-13-3038 (D.N.J.) |
May 10, 2013 |
Hon. Joel A. Pisano |
Vimovo®(naproxen / esomeprazole magnesium delayed-release tablets) |
5,714,504 6,369,085 6,875,872 7,411,070 7,745,466 |
|
Purdue Pharma L.P. v. Impax Labs., Inc., 13-3188 (S.D.N.Y.) |
May 10, 2013 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride) |
8,337,888 |
|
Bayer Pharma AG v. Par Pharma., Inc., 13-0845 (D. Del.) |
May 14, 2013 |
Hon. Gregory M. Sleet |
Staxyn®(vardenafil hydrochloride orally disintegrating tablets) |
6,362,178 7,696,206 |
|
Senju Pharma. Co., Ltd. v. Strides, Inc., 13-0851 (D. Del.) |
May 15, 2013 |
Hon. Sue L. Robinson |
Zymar®/ Zymaxid®(gatifloxacin ophthalmic solution) |
6,333,045 |
|
Abbvie, Inc. v. Hetero USA Inc., 13-0852 (D. Del.) |
May 15, 2013 |
Hon. Richard G. Andrews |
Norvir®(ritonavir tablets) |
7,148,359 7,364,752 8,268,349 6,037,157 6,703,403 |
|
Endo Pharma. Inc. v. Par Pharma. Co., Inc., 13-3284 (S.D.N.Y.) |
May 15, 2013 |
Hon. Thomas P. Griesa |
Opana®ER CRF (oxymorphone hydrochloride extended-release tablets) |
7,851,482 8,309,122 8,329,216 |
|
Endo Pharma. Inc. v. Teva Pharma. USA Inc., 13-3285 (S.D.N.Y.) |
May 15, 2013 |
Hon. Thomas P. Griesa |
Opana®ER CRF (oxymorphone hydrochloride extended-release tablets) |
7,851,482 8,309,122 8,329,216 |
|
Endo Pharma. Inc. v. Mallinckrodt, LLC, 13-3286 (S.D.N.Y.) |
May 15, 2013 |
Hon. Thomas P. Griesa |
Opana®ER CRF (oxymorphone hydrochloride extended-release tablets) |
7,851,482 8,309,122 8,329,216 |
|
Endo Pharma. Inc. v. Sandoz, Inc., 13-3287 (S.D.N.Y.) |
May 15, 2013 |
Hon. Thomas P. Griesa |
Opana®ER CRF (oxymorphone hydrochloride extended-release tablets) |
7,851,482 8,309,122 8,329,216 |
|
Endo Pharma. Inc. v. Roxane Labs., Inc., 13-3288 (S.D.N.Y.) |
May 15, 2013 |
Hon. Thomas P. Griesa |
Opana®ER CRF (oxymorphone hydrochloride extended-release tablets) |
7,851,482 8,309,122 8,329,216 |
|
Purdue Pharma L.P. v. Amneal Pharma., LLC, 13-3372 (S.D.N.Y.) |
May 17, 2013 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride) |
8,337,888 |
|
Purdue Pharma L.P. v. Par Pharma., Inc., 13-3374 (S.D.N.Y.) |
May 17, 2013 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride) |
8,337,888 8,309,060 |
|
Fresenius Kabi USA, LLC v. Dr. Reddy’s Labs., Ltd., 13-0925 (D. Del.) |
May 23, 2013 |
Hon. Sue L. Robinson |
Diprivan®(propofol 1% injectable emulsion) |
5,714,520 5,731,355 5,731,356 5,908,869 |
|
Eli Lilly and Co. v. Perrigo Co., 13-0851 (S.D. Ind.) |
May 24, 2013 |
Hon. Sarah Evans Barker |
Axiron®(testosterone metered transdermal solution) |
8,435,944 8,419,307 8,177,449 |
|
Takeda Pharma. Co., Ltd. v. Impax Labs., Inc., 13-2416 (N.D. Cal.) |
May 29, 2013 |
Hon. Elizabeth D. Laporte |
Dexilant®(dexlansoprazole delayed-release capsules) |
8,173,158 |
|
Takeda Pharma. Co., Ltd. v. Sandoz Inc., 13-2418 (N.D. Cal.) |
May 29, 2013 |
Hon. Donna M. Ryu |
Dexilant®(dexlansoprazole delayed-release capsules) |
8,173,158 |
|
Takeda Pharma. Co., Ltd. v. TWI Pharma. Inc., 13-2420 (N.D. Cal.) |
May 29, 2013 |
Hon. Laurel Beeler |
Dexilant®(dexlansoprazole delayed-release capsules) |
8,173,158 |
|
Avanir Pharma. Inc. v. Sandoz, Inc., 13-0961 (D. Del.) |
May 30, 2013 |
Hon. Leonard P. Stark |
Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules) |
7,659,282 8,227,484 RE38,115 |
|
Merck & CIE v. Watson Labs., Inc., 13-0978 (D. Del.) |
June 4, 2013 |
Hon. Richard G. Andrews |
Safyral®(drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets) |
6,441,168 |
|
Pfizer Inc. v. Dr. Reddy’s Labs., Ltd., 13-0989 (D. Del.) |
June 4, 2013 |
Hon. Sue L. Robinson |
Pristiq®(O-desmethylvenlafaxine succinate extended-release tablets) |
6,673,838 8,269,040 |
|
Merck & CIE v. Watson Labs., Inc., 13-0990 (D. Nev.) |
June 4, 2013 |
Hon. Andrew P. Gordon |
Safyral®(drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets) |
6,441,168 |
|
Abbvie, Inc. v. Dr. Reddy’s Labs. Ltd., 13-1012 (D. Del.) |
June 5, 2013 |
Hon. Gregory M. Sleet |
Zemplar®(paricalcitol for injection) |
6,136,799 6,361,758 5,597,815 |
|
Fresenius Kabi USA, LLC v. Watson Labs., Inc., 13-1015 (D. Del.) |
June 6, 2013 |
Hon. Sue L. Robinson |
Diprivan®(propofol 1% injectable emulsion) |
5,714,520 5,731,355 5,731,356 5,908,869 |
|
Sun Pharma Global FZE v. Novartis Pharma. Corp., 13-3542 (D.N.J.) |
June 7, 2013 |
Hon. Dennis M. Cavanaugh |
Gleevac®(imatinib mesylate tablets) |
6,894,051 |
|
Abbvie, Inc. v. Mylan Pharma., Inc., 13-1072 (D. Del.) |
June 14, 2013 |
Hon. Richard G. Andrews |
Norvir®(ritonavir soft gelatin capsule) |
6,232,333 7,141,593 7,432,294 |
|
Insite Vision Inc. v. Mylan Pharma. Inc., 13-3720 (D.N.J.) |
June 14, 2013 |
Hon. Mary L. Cooper |
AzaSite®(azithromycin ophthalmic solution) |
6,861,411 6,239,113 6,569,443 7,056,893 |
|
Senju Pharma. Co., Ltd. v. Apotex Inc., 13-4132 (S.D.N.Y.) |
June 14, 2013 |
Hon. Paul A. Crotty |
Istalol®(timolol maleate ophthalmic solution) |
6,335,335 |
|
Accord Healthcare, Inc. v. Eli Lilly and Co., IPR2013-00356 (PTAB) |
June 14, 2013 |
N/A |
Alimta®(pemetrexed for injection) |
7,772,209 |
|
Kissei Pharma. Co., Ltd. v. Hetero USA Inc., 13-1091 (D. Del.) |
June 17, 2013 |
Hon. Leonard P. Stark |
Rapaflo®(silodosin capsules) |
5,387,603 |
|
Kissei Pharma. Co., Ltd. v. Sandoz Inc., 13-1092 (D. Del.) |
June 17, 2013 |
Hon. Leonard P. Stark |
Rapaflo®(silodosin capsules) |
5,387,603 |
|
Alza Corp. v. Par Pharma., Inc., 13-1104 (D. Del.) |
June 19, 2013 |
Hon. Richard G. Andrews |
Concerta®(methylphenidate hydrochloride) |
8,163,798 |
|
Amneal Pharma., LLC v. Supernus Pharma, LLC, IPR2013-00368 (PTAB) |
June 20, 2013 |
N/A |
Oracea®(doxycycline) |
8,206,740 |
|
Amneal Pharma., LLC v. Supernus Pharma, LLC, IPR2013-00371 (PTAB) |
June 20, 2013 |
N/A |
Oracea®(doxycycline) |
8,394,405 |
|
Amneal Pharma., LLC v. Supernus Pharma, LLC, IPR2013-00372 (PTAB) |
June 20, 2013 |
N/A |
Oracea®(doxycycline) |
8,394,406 |
|
Pfizer Inc. v. Alkem Labs., Ltd., 13-1110 (D. Del.) |
June 21, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Pfizer Inc. v. Sandoz, Inc., 13-1111 (D. Del.) |
June 21, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Par Pharma., Inc. v. Breckenridge Pharma., Inc., 13-1114 (D. Del.) |
June 21, 2013 |
Hon. Sue L. Robinson |
Megace®ES (megestrol acetate oral suspension) |
6,592,903 7,101,576 |
|
Endo Pharma. Inc. v. Ranbaxy Labs. Ltd., 13-4343 (S.D.N.Y.) |
June 21, 2013 |
Unassigned |
Opana®ER CRF (oxymorphone hydrochloride extended-release tablets) |
7,851,482 8,309,122 8,329,216 |
|
Pfizer Inc. v. Alkem Labs., Ltd., 13-4628 (N.D. Ill.) |
June 24, 2013 |
Hon. Joan B. Gottschall |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Janssen Products, L.P. v. Lupin Ltd., 13-3891 (D.N.J.) |
June 24, 2013 |
Hon. William H. Walls |
Prezista®(darunavir tablets) |
7,700,645 7,126,015 7,595,408 |
|
Alza Corp. v. Osmotica Kereskedelmi Es Szolgaltato Kft, 13-1126 (D. Del.) |
June 24, 2013 |
Hon. Richard G. Andrews |
Concerta®(methylphenidate hydrochloride) |
8,163,798 |
|
Alpex Pharma, S.A. v. Zydus Pharma. USA, Inc., 13-1143 (D. Del.) |
June 26, 2013 |
Hon. Sue L. Robinson |
Suprenza®(phentermine hydrochloride tablets) |
6,149,938 |
|
Alza Corp. v. Osmotica Kereskedelmi Es Szolgaltato Kft |
June 26, 2013 |
Hon. Elaine E. Bucklo |
Concerta®(methylphenidate hydrochloride) |
8,163,798 |
|
Par Pharma., Inc. v. Breckenridge Pharma., Inc., 13-4000 (D.N.J.) |
June 27, 2013 |
Hon. Kevin McNulty |
Megace®ES (megestrol acetate oral suspension) |
6,592,903 7,101,576 |
|
Merck, Sharp & Dohme Corp. v. Cipla USA, Inc., 13-4017 (D.N.J.) |
June 27, 2013 |
Hon. Jerome B. Simandle |
Sustiva®(efavirenz tablets) |
6,639,071 6,939,964 |
|
U.S. Dept. of Health and Human Services v. Lupin Ltd., 13-4039 (D.N.J.) |
June 27, 2013 |
Hon. William H. Walls |
Prezista®(darunavir tablets) |
7,470,506 |
|
UCB Inc. v. Zydus Pharma. (USA), Inc., 13-4021 (D.N.J.) |
June 28, 2013 |
Hon. Michael A. Shipp |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
AstraZeneca AB v. Mylan Pharma., 13-4022 (D.N.J.) |
June 28, 2013 |
Hon. Joel A. Pisano |
Vimovo®(naproxen / esomeprazole magnesium delayed-release tablets) |
5,714,504 6,369,085 6,875,872 7,411,070 7,745,466 5,948,789 |
|
UCB Inc. v. Teva Pharma. USA, Inc., 13-1148 (D. Del.) |
June 28, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
Pfizer Inc. v. Lupin Ltd., 13-1153 (D. Del.) |
June 28, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Pfizer Inc. v. Zydus Pharma. (USA), Inc., 13-1154 (D. Del.) |
June 28, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Pfizer Inc. v. Accord Healthcare Inc., USA, 13-1155 (D. Del.) |
June 28, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Pfizer Inc. v. Amerigan Pharma., Inc., 13-1156 (D. Del.) |
June 28, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Pfizer Inc. v. Amneal Pharma., LLC, 13-1157 (D. Del.) |
June 28, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Pfizer Inc. v. Impax Labs., Inc., 13-1158 (D. Del.) |
June 28, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
